JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (11): 7-12.doi: 10.6040/j.issn.1671-7554.0.2016.227

Previous Articles     Next Articles

Mechanical function of HIPK2 in epithelial-mesenchymal transition and metastasis of non-small cell lung cancer

ZHENG Hui, WEI Guangwei   

  1. Department of Anatomy, School of Medicine, Shandong University, Jinan 250012, Shandong, China
  • Received:2016-03-07 Online:2016-11-10 Published:2016-11-10

PDF (PC)

342

Abstract: Objective To investigate the role of homeodomain interacting protein kinase 2(HIPK2)in epithelial-mesenchymal transition(EMT)and metastasis in non-small cell lung cancer(NSCLC)cells, and to explore the possible mechanism. Methods The A549 and H520 cells were divided into high expression group and control group, then transfected with pcDNA3.1-HIPK2 and pcDNA3.1-Vector with Lipofectamine 2000. HIPK2 silenced and control cell lines were constructed in A549 by the transfection of GV248 shHIPK2 and GV248 shVector with lentivirus. GV248 shZEB1 and GV248 shVector were transfected with Lipofectamine 2000 in A549 cells in which HIPK2 was silenced. The expression of HIPK2 and EMT markers were detected by Western blotting. The migration and invasion ability of cells were detected through wound scratch assay, Transwell assay and Matrigel assay. Results Compared with control group, the expression of epithelial cell markers in high expression group were enhanced(P<0.01), and the expression of mesenchymal cell markers were descended(P<0.01), which repressed the EMT process. Meanwhile, wound scratch assay showed that the migrated distance of high expression group were less than the control group(P<0.05). Transwell assay and Matrigel assay showed that the number of cells that migrated and invaded through the membrane were obviously 山 东 大 学 学 报 (医 学 版)54卷11期 -郑荟,等.HIPK2抑制非小细胞肺癌上皮间质转化及迁移侵袭的作用及机制 \=-less than those in control group(P<0.01). Conversely, silencing HIPK2 generated the opposite effects. The enhanced EMT and metastasis induced by HIPK2 silencing could be reversed by interfering zinc finger E-box binding homeobox 1(ZEB1). Conclusion HIPK2 represses EMT, migration and invasion of NSCLC cells, and the possible mechanism is related to transcription factor ZEB1.

Key words: Carcinoma, non-small cell lung, Epithelial-mesenchymal transition, Homeodomain interacting protein kinase 2, Migration, Invasion

CLC Number: 

  • R734.2
[1] Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: new biological insights and recent therapeutic advances[J]. CA Cancer J Clin, 2011, 61(2):91-112.
[2] Shimizu H, Yamagishi S, Chiba H, et al. Methionine aminopeptidase 2 as a potential therapeutic target for human non-small-cell lung cancers[J]. Adv Clin Exp Med, 2016, 25(1):117-128.
[3] Kim YH, Choi CY, Lee SJ, et al. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors[J]. J Biol Chem, 1998, 273(40):25875-25879.
[4] Puca R, Nardinocchi L, Givol D, et al. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells[J]. Oncogene, 2010, 29(31): 4378- 4387.
[5] Trapasso F, Aqeilan RI, Iuliano R, et al. Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro[J]. DNA Cell Biol, 2009, 28(4):161-167.
[6] Valente D, Bossi G, Moncada A, et al. HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity[J]. Oncotarget, 2015, 6(12):10320-10334.
[7] Nodale C, Sheffer M, Jacob-Hirsch J, et al. HIPK2 downregulates vimentin and inhibits breast cancer cell invasion[J]. Cancer Biol Ther, 2012, 13(4):198-205.
[8] Puca R, Nardinocchi L, Pistritto G, et al. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells[J]. Gynecol Oncol, 2008, 109(3):403-410.
[9] 屈若祎, 周宝森. 2004-2010 年中国肺癌死亡分布及趋势分析[J].中国卫生统计, 2014,31(6):932-935. QU Ruoyi, ZHOU Baosen. Analysis of distribution and trend of lung cancer mortality in China between 2004-2010[J]. Chinese Journal of Health Statistics, 2014, 31(6):932-935.
[10] Tanoue LT, Tanner NT, Gould MK, et al. Lung cancer screening[J]. Am J Respir Crit Care Med, 2015, 191(1):19-33.
[11] Soltermann A. Epithelial-mesenchymal transition in non-small cell lung cancer[J]. Pathologe, 2012, 33 Suppl 2:311-317.
[12] Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression[J]. J Mammary Gland Biol Neoplasia, 2010, 15(2):117-134.
[13] Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways[J]. Cancer Res, 2008, 68(10):3645-3654.
[14] Kokudo T, Suzuki Y, Yoshimatsu Y, et al. Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells[J]. J Cell Sci, 2008, 121(Pt 20):3317-3324.
[15] Aigner K, Dampier B, Descovich L, et al. The transcription factor ZEB1(deltaEF1)promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity[J]. Oncogene, 2007, 26(49):6979-6988.
[16] Eger A, Aigner K, Sonderegger S, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells[J]. Oncogene, 2005, 24(14):2375-2385.
[17] Wei G, Ku S, Ma GK, et al. HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis[J]. Proc Natl Acad Sci U S A, 2007, 104(32):13040-13045.
[18] Kim EA, Kim JE, Sung KS, et al. Homeodomain-interacting protein kinase 2(HIPK2)targets beta-catenin for phosphorylation and proteasomal degradation[J]. Biochem Biophys Res Commun, 2010, 394(4):966-971.
[1] WANG Wei, WANG Yi-Feng, ZHANG Ling-Mei, LIN Qiong-Yan, HUANG Ju. umorigenicity and invasion of side population in human ovarian epithelial cancer OVCAR3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 8-11.
[2] SUN Yifeng, GAO Yu, LIANG Yongyuan, GAO Yang. Expression of CPLX2 and its in vitro effects on the proliferation migration and invasion of hepatocellular carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 34-39.
[3] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32-37.
[4] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38-46.
[5] WANG Tiantian, CHEN Jie. Expression and clinical significance of EFEMP2 in endometrial cancer tissues and cell [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 52-58.
[6] LU Heng, LIU Yanguo, LI Shuguang, CHEN Xiaokang, TIAN Qi, YI Cuihua, WANG Xiuwen. Regulation of epithelial ovarian carcinoma SKOV-3 cell migration by YKL-40 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 33-38.
[7] WANG Wei, CAO Yushan, SUN Daquan, HUANG Xiaoqiong, XU Guoqiang. Role of human TIMP-2 protein in the migration and invasion of hepatocellular carcinoma cell [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 11-17.
[8] HE Wubin, SU Rongjian. Pulsatilla saponin D combined with sorafenib against hepatocellular carcinoma cell invasion and metastasis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 18-22.
[9] MA Xue, ZHANG Bin, HAN Chunyao, LIU Mingyuan, HAO Lijing, GE Shuqing, XUE Zhongyuan. Down-regulation of α-catulin inhibits the invasion and migration of human tongue squamous cancer cell line Tscca in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(6): 12-15.
[10] ZHANG Zhan, XU Xiangfeng, LIU Haidong, WANG Wei. Diagnostic value of MRI in the T-staging of cervical cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 70-73.
[11] LÜ Shuqing, WEI Wei, ZHANG Cancan, TIAN Yongjie. Mechanism of HGF/PARP-1 signaling pathway regulating invasion and metastasis of ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 1-7.
[12] ZHOU Jing, CHANG Xiaotian, ZHOU Ting, CUI Yingying, ZHANG Bei, RONG Fengnian. Effects of PADI4 silence on ovarian cancer cell line OVCAR3 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 48-53.
[13] YAO Zhong, CHEN Weiliang, XU Yangyang, HE Ying, QU Xun, LI Xingang. Galectin-9 inhibits proliferation and migration of glioma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(4): 1-5.
[14] HAN Xiao, XUE Hao, YAN Shaofeng, GUO Xing, LI Tong, GUO Xiaofan, GAO Xiao, LI Gang. Effects of miR-584 on the invasion and migration of human glioblastoma U251 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(4): 16-21.
[15] GAO Feng, KANG Bai, YANG Hongming, ZHAO Tingkun, QU Meihua, WANG Jinhong. Expression of the cutaneous T-cell lymphoma-associated antigen 5 in tumor cell lines [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 41-45.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd